Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
398 studies found for:    Open Studies | "Ovarian Diseases"
Show Display Options
Rank Status Study
21 Recruiting Ovarian Stem Cells From Women With Ovarian Insufficiency
Condition: Infertility
Intervention:
22 Recruiting DOD Long-Term Survivors of Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Behavioral: Quality of life questionaire
23 Unknown  Research Study in Patients With Advanced Epithelial Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Genetic: comparative genomic hybridization;   Genetic: cytogenetic analysis;   Genetic: gene rearrangement analysis;   Genetic: microarray analysis;   Genetic: mutation analysis;   Genetic: polymerase chain reaction
24 Recruiting Hypodontia and Ovarian Cancer
Conditions: Ovarian Cancer;   Hypodontia;   Breast Cancer;   Colon Cancer
Intervention:
25 Recruiting Oxford Ovarian Cancer Predict Chemotherapy Response 01
Condition: Ovarian Cancer
Intervention:
26 Recruiting Study of Birinapant in Combination With Conatumumab in Subjects With Relapsed Ovarian Cancer
Conditions: Relapsed Epithelial Ovarian Cancer;   Relapsed Primary Peritoneal Cancer;   Relapsed Fallopian Tube Cancer
Interventions: Drug: Birinapant;   Drug: Conatumumab
27 Recruiting Study of ONT-10 and Varlilumab to Treat Advanced Ovarian or Breast Cancer
Conditions: Advanced Breast Carcinoma;   Advanced Ovarian Carcinoma
Intervention: Biological: ONT-10, Varlilumab combination
28 Recruiting EWOC-1 Trial: Carboplatin +/- Paclitaxel in Vulnerable Elderly Patients With Stage III-IV Advanced Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: Paclitaxel + Carboplatin every 3 weeks;   Drug: Carboplatin monotherapy every 3 weeks;   Drug: Weekly Paclitaxel and Carboplatin
29 Unknown  Maintenance Treatment for Ovarian Carcinoma in Remission by an Antiangiogenic Treatment Strategy
Condition: Ovarian Carcinoma
Intervention: Drug: Cytophosphan, Celecoxib, Methotrexate
30 Recruiting Efficacy Study Comparing the Effect of Clomiphencitrate to an Antagonist Protocol
Conditions: Female Infertility;   Ovarian Insufficiency
Interventions: Drug: High Dose Clomiphencitrat;   Drug: Low Dose Clomiphencitrat;   Drug: High Dose Placebo;   Drug: Low dose Placebo
31 Recruiting Oxidative Stress and Bisphenol A (BPA) Impact With Polycystic Ovary Syndrome (PCOS)
Conditions: Oxidative Stress;   Endocrine Disrupting Chemicals;   Polycystic Ovary Syndrome
Intervention:
32 Unknown  GnRH Agonist (GnRHa) Withdrawal at Late Stage of Long Protocol and the Incidence of Ovarian Hyper-stimulation
Condition: Infertile High-risk Patients With Polycystic Ovaries
Intervention: Drug: a drug withdrawal during the long protocol
33 Recruiting Phase Ib Trial of Two Folate Binding Protein Peptide Vaccines (E39 and J65) in Breast and Ovarian Cancer Patients
Conditions: Breast Cancer;   Ovarian Cancer
Interventions: Biological: E39 peptide vaccine;   Biological: E39 vaccine then J65 vaccine;   Biological: J65 vaccine then E39 vaccine
34 Recruiting Social Cognition and Turner Syndrome
Condition: Turner Syndrome
Intervention: Other: Evaluation of 45,X Turner syndrome patients
35 Recruiting Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
Conditions: Breast Cancer;   Hereditary Breast and Ovarian Cancer
Intervention:
36 Recruiting Neoadjuvant Therapy for Ovarian Cancer
Conditions: Epithelial Ovarian Cancer;   Primary Peritoneal Cancer;   Fallopian Tube Cancer
Intervention: Drug: Carboplatin, paclitaxel, and bevacizumab
37 Recruiting Effect of Metformin on Sensitivity of the Gonadotropin-releasing Hormone (GnRH) Pulse Generator to Suppression by Estradiol and Progesterone
Conditions: Polycystic Ovary Syndrome;   Hyperandrogenism
Interventions: Drug: Metformin;   Drug: Progesterone;   Drug: estrace
38 Recruiting BOVARI: A Non-Interventional Study of Avastin (Bevacizumab) as Front-Line Treatment in Patients With Ovarian Cancer
Condition: Ovarian Cancer, Peritoneal Neoplasms
Intervention:
39 Recruiting Deep Reading as a Contemplative Practice for Women With Primary Ovarian Insufficiency
Condition: Ovarian Insufficiency
Intervention: Other: Group reading and discussion
40 Unknown  Study With Wee-1 Inhibitor MK-1775 and Carboplatin to Treat p53 Mutated Refractory and Resistant Ovarian Cancer
Condition: Epithelial Ovarian Cancer
Intervention: Drug: MK-1775 and carboplatin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years